Interferon-α, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia - Burchert, Andreas; Wölfl, Stefan; Schmidt, Manuel; Brendel, Cornelia; Denecke, Barbara; Cai, Dali; Odyvanova, Larissa; Lahaye, Tanja; Müller, Martin Christian; Berg, Thomas; Gschaidmeier, Harald; Wittig, Burghardt; et al. (Blood, 2003)
Gesehen am 13.05.2022